Cambridge Trust’s Scotiabank BNS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q3
Sell
-223
Closed -$13K 847
2022
Q2
$13K Hold
223
﹤0.01% 652
2022
Q1
$16K Hold
223
﹤0.01% 688
2021
Q4
$16K Buy
+223
New +$14.7K ﹤0.01% 731
2019
Q2
Sell
-4,022
Closed -$214K 255
2019
Q1
$214K Sell
4,022
-1,178
-23% -$64.5K 0.01% 230
2018
Q4
$259K Sell
5,200
-235
-4% -$12.7K 0.02% 214
2018
Q3
$324K Buy
5,435
+135
+3% +$7.89K 0.02% 208
2018
Q2
$303K Hold
5,300
0.02% 209
2018
Q1
$327K Hold
5,300
0.02% 211
2017
Q4
$342K Hold
5,300
0.02% 212
2017
Q3
$340K Hold
5,300
0.02% 210
2017
Q2
$319K Hold
5,300
0.02% 215
2017
Q1
$311K Buy
5,300
+500
+10% +$29.7K 0.02% 229
2016
Q4
$268K Buy
4,800
+1,000
+26% +$54.5K 0.02% 228
2016
Q3
$201K Buy
+3,800
New +$197K 0.01% 251

Other funds holding BNS

Cambridge Trust's BNS Position: Q3 2022 in Review

Cambridge Trust sold out of Scotiabank (BNS) in Q3 2022, closing a stake of 223 shares — an estimated $13K sold.

Cambridge Trust first reported a position in BNS in Q3 2016 and held it in 14 quarters. The position peaked at $342K in Q4 2017. 417 funds tracked by Wall St. Rank hold BNS as of Q3 2022.

  • Cambridge Trust reported no remaining Scotiabank position as of Q3 2022 after selling out during the quarter.
  • Cambridge Trust sold 223 Scotiabank shares in Q3 2022, an estimated $13K.
  • Cambridge Trust first reported a position in Scotiabank in Q3 2016 and held it in 14 quarters.
  • Cambridge Trust's Scotiabank position peaked at $342K in Q4 2017.
  • 417 funds tracked by Wall St. Rank held Scotiabank as of Q3 2022.

Based on Cambridge Trust's 13F filing for Q3 2022, filed 8 Nov 2022.